<DOC>
	<DOC>NCT02271529</DOC>
	<brief_summary>The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.</brief_summary>
	<brief_title>Zilver PTX Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Patient has symptomatic vascular disease of the native abovetheknee femoropopliteal arteries Patient has atherosclerotic lesion of the abovetheknee femoropopliteal artery Patient is &lt; 18 years of age Patient unable to complete required followup assessments Patient unwilling to sign and date the informed consent Simultaneous participation in another investigational drug or device study Pregnant, breastfeeding or planning to become pregnant in the next 5 years Additional medical/anatomical restrictions as specified in the Clinical Investigation Plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Femoral Artery</keyword>
	<keyword>Drug-Eluting Stent</keyword>
</DOC>